Objective: The objective of this study was to increase the solubility and dissolution rate of paliperidone (PAL) by preparing its nanocrystals using different hydrophilic carriers by antisolvent precipitation technique.
INTRODUCTION
Pharmaceutical scientists in industry, especially, involved in drug discovery and formulation development face major problems of poor aqueous solubility and slow dissolution rates of drugs [1, 2] . Insoluble drugs are not adequately wetted and dissolved in GIT after oral administration, consequently affecting their in vivo performance [2] . Therefore, there is a need to find a universal remedy which will increase the solubility of poorly soluble drugs; this can be achieved by nanoparticle (NP) engineering process [3] [4] [5] by reducing the particle size to nano range [6, 7] . Paliperidone (PAL) is a weakly acidic, poorly soluble antipsychotic drug. The present study aims to prepare PAL nanocrystals using different hydrophilic carriers by antisolvent precipitation technique to facilitate the enhancement of solubility, dissolution, and bioavailability in turn [8, 9] .
MATERIALS AND METHODS

Materials
PAL was obtained from Cadila Pharmaceuticals, Ahmedabad, India. Plasdone S-630, Povidone K25, and Povidone K30 were generously gifted by Ashland, Wayne, New Jersey, USA. All other chemicals used were of analytical grade.
Preparation of PAL NPs
PAL nanocrystals with hydrophilic carriers (Plasdone S630/Povidone K25/Povidone K30) of different weight ratios were prepared by dissolving an appropriate amount of carrier in 200 ml of mili-Q water and the solution stirred at 1000 rpm on a magnetic stirrer. A specified amount of PAL was dissolved in 10 ml chloroform to prepare an organic solution, and this solution was then injected into 200 ml aqueous solution containing hydrophilic carrier maintained at 37±2°C under constant stirring at 1000 rpm (REMI 1 ML Magnetic Stirrer) [10] . The obtained NPs were subsequently stored in a vacuum oven at room temperature for 48 h to remove the residual solvent. The dried NPs were pulverized and sieved through sieve number #170. The samples were kept in desiccators and further stored in airtight vials (Table 1) [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] .
Preparation of physical mixture (PM)
PMs of different hydrophilic carriers with drug were prepared by triturating in a mortar and pestle for 30 min.
Determination of saturation solubility
Saturation solubility of PAL, PM, and NPs was determined by adding the known excess amount to 100 ml HPLC grade water (pH 7.00 at 20°C) which was then shaken at 100 rpm on magnetic stirrer for 24 h. After centrifugation and filtration through 0.45 µm Nylon syringe filter, the concentration of PAL was determined spectrophotometrically at 275 nm. Every sample was analyzed in triplicate, and the mean values and standard deviations were reported [21, 22] .
Ratio optimization
Based on the highest solubility and drug content, the optimized batch was selected and filled in capsules and used for further characterization.
Fourier-transform infrared spectroscopy (FT-IR)
FT-IR spectra of PAL alone and PALNPs were carried out to check compatibility of the drug with polymers. PALNP was mixed with KBr Rajkumar and Surendra (IR grade) in the ratio of 1:100. The dispersion was then scanned using FT-IR Spectrophotometer (Shimadzu, Japan). The spectra of NPs were compared with that of the spectra of pure drug.
Differential scanning calorimetry (DSC)
A DSC-60 (Shimadzu, Japan) was calibrated using an indium standard. The samples were placed in hermetically sealed aluminum pans and heated from 30°C to 200°C at 10°C/min and with a nitrogen purge of 40 ml/min.
X-ray diffraction (XRD)
Powder XRD pattern was traced employing X-ray diffractometer (Model No. 3000, Seifert, Germany) for the samples, using Ni-filtered Cu-K radiation, a voltage of 40 kV, a current of 30 mA radiation scattered in the crystalline regions of the sample, which was measured with a vertical goniometer. Pattern was obtained using a step width of 0.04° with a detector resolution in 2θ (diffraction angle) between 10° and 50° at ambient temperature.
Scanning electron microscopy (SEM)
The morphologies of PAL and nano-sized PAL were examined using a scanning electron microscope (JEOL JSM-7001F, Japan) operated at an accelerating voltage of 15 kV and a secondary detector. Freshly prepared dispersion of sample was deposited on glass slides following the evaporation of the solvent and coated with gold.
Particle size measurement
Particle size analysis of the PAL NPs was performed by Dynamic Light Scattering (Scirocco 2000 (A), Malvern Instrument's, UK). The relative frequency of the diameter of the particle was obtained by calculation based on volume distribution. The particle size at 90% of the total fraction was used as particle size.
In vitro drug release studies
In vitro drug release study was performed using USP Apparatus I (Lab India Ltd., India) at 100 rpm with 900 mL of degassed water at 37±0.5°C. Six capsules of each batch containing nanocrystals equivalent to 6mg PAL were tested. Sink condition was maintained in degassed water. Sample of the dissolution media was removed through an automated sampling system at predetermined time interval (0, 5, 10, 15, 30, 45, and 60 min) and simultaneously analyzed spectrophotometrically at λmax of 275 nm (ultraviolet-1700 Shimadzu, Japan). In vitro release studies of PAL, PMs, and PALNPs were carried out, and the data of dissolution study are shown as mean±standard deviation (n=6) [23] .
In vivo antipsychotic activity evaluation of PAL and PALNP4 on bar test
The protocol was approved and implemented as per the guidelines of the Institutional Animal Ethical Committee. The severity of catalepsy in individual mouse (n=6) was determined as per the procedure described by Khisti et al., 2002 [24] . Briefly, placing the forepaws of the mice over a wooden bar 0.4 cm in diameter fixed to a height of 3.5 cm above the tabletop and described as descent latency. The time at which mice brought both forepaws down to the tabletop was recorded, with a maximum cutoff time of 300 s. Measurement of catalepsy was carried out at 0 min, 30 min, and 60 min after the administration of vehicle or PAL or PALNP4.
RESULTS AND DISCUSSION
Solubility study of PAL and PALNPs
The solubility of pure PAL in distilled water was found to be 1.56 μg/ml indicating poor solubility. The solubility studies showed a linear increase in drug solubility with increased carrier levels. At 0.7% concentration of Plasdone S630, Povidone K25, and Povidone K30, the increase in solubility was 12, 9, and 6 folds, respectively, compared with pure drug (Table 2 and Fig. 1 ). The increase in solubility in the presence of carrier can probably be explained by increased wettability of PAL. Hydrophilic carriers are known to interact with drug molecules mainly by electrostatic forces and occasionally by other type of forces such as hydrogen bonds [25] [26] [27] [28] .
Assay of PAL
The drug content of the prepared NPs was found to be in the range 95-101% indicating the application of the present method for the preparation of NPs with high content uniformity.
Dissolution studies of PAL, PALNPs, and PMs with different carriers
The dissolution profiles showed a significant enhancement in drug release characteristics of NP and PM compared to pure PAL. The DE60 min, IDR in 15 min, amount of release in 15 min (Q15 min), and time taken to release 75% (t75% min) have shown higher release from NP than PM and pure drug, respectively (Table 3 ). Higher dissolution of NPs compared to PMs of the carrier may be due to wettability of the carrier and transformation of crystalline state of the drug to nanocrystalline in NP. Based on dissolution parameters, NP4 considered as best formulation among the other and used for further evaluation studies. 
Powder XRD analysis
The powder XRD pattern of PAL and PALNP4 as shown Figs. 6 and 7 showed sharp high-intensity peaks indicating the presence of crystalline form.
SEM
From the scanning electron microgram images as shown in Figs. 8 and 9 , it can be seen that the pure drug particles existed as predominantly needle-shaped crystals; however, PAL NPs obtained by antisolvent precipitation are spherical or irregular in shape with a narrow PNP in the presence of Plasdone S630. Moreover, the nano-sized particles Rajkumar and Surendra were very thin revealed by the presence of fragments. The images also revealed that these agglomerates or particle assemblies were composed of a large number of individual NPs.
Particle size measurement
The dynamic light scattering measurements as depicted in Fig. 10 show that all the particles falls below 100 nm with mean particle size 52.2 nm and with uniform particle size distribution.
In vivo antipsychotic activity evaluation of PAL and PALNP4 on bar test Dopamine D2-like receptor antagonist shows increased descent latencies (tendency of animals to remain on bar). In the present study, mice treated with PAL or PALNP4 here exhibited significant change (p<0.001) in descent latency as compared to that of vehicletreated groups at respective time intervals indicating that PAL and PALNP4 elicited significant induction of cataleptic behavior (Table 4 and Fig. 11 ). The induction of cataleptic behavior is the indication of the effect of antipsychotic agent(s).
CONCLUSION
PAL was successfully formulated in nanocrystals with desired characteristics of size and shape, with reasonable stability and entrapment with significantly greater solubility with faster dissolution rate compared to pure drug. Antisolvent precipitation can thus be a simple and effective approach to produce nanocrystals of poorly water-soluble drugs with hydrophilic carriers. In vitro release rate studies showed that the maximum drug release was found in the optimized PAL NPs 4. This may be due to increased surface area due to decreased particle size and improved wettability. Furthermore, from in vivo study, it seems that PALNP elicited significant antipsychotic-like activity as compared to PAL and vehicle control.
